Xcout Intel
Angiex, Inc.
Angiex Inc. is a private biotechnology company that focuses on novel biology to address the hallmarks of cancer lethality. The firm develops safe and effective cancer therapies and is located in Cambridge, Massachusetts.
Subscribe to see Angiex, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Angiex, Inc. at a glance
Angiex, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $31M in November 2025. Xcout tracks 17 named people at Angiex, Inc., including Paul Jaminet (CEO).
Angiex, Inc. leadership
- Paul JaminetCEO
- Jeff SacherChief Financial Officer
- Glen WeissChief Medical Officer
- Iain DukesExecutive Chairman
- Paul JaminetFounder & CEO
- Hal DvorakFounder, SAB Chair
11 more named people on record for Angiex, Inc., with roles, board committees and tenure — see the full roster →
Angiex, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $31M | 1 named | |
| SEC Form D filing | $22M | — | |
| Series B | $45M | — | |
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Angiex, Inc. competitors
A few of Angiex, Inc.'s closest competitors — see the full list of competitors and alternatives →
Ankyra Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2019 and headquartered in Cambridge, Massachusetts. The enterprise specializes in developing proprietary anchored cytokine therapies designed to treat various cancers and immune diseases. Its platform technology localizes immune-stimulatory treatments within tumors to maximize therapeutic efficacy while minimizing systemic toxicity.
TargAnox was an early-stage biotechnology and drug discovery company headquartered in Cambridge, Massachusetts. The firm focused on developing novel treatments and biotech drugs to prevent oxidative stress diseases, including conditions related to oncology and metabolic diseases. Currently, the company is permanently closed.
Crossbow Therapeutics is a privately held biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts. The company develops potent antibody therapeutics aimed at expanding treatment options and combating cancer.
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Get Angiex, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Angiex, Inc. in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access